Safety of bowel cleasing agents for colon capsule endoscopy and conventional colonoscopy
Phase 4
- Conditions
- Colorectal diseases
- Registration Number
- JPRN-UMIN000013041
- Lead Sponsor
- Fujita Health University School of Medicine, Department of Gastroenterology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients with dysphasia 2)Patietns who had allergy to agents used in this study. 3)Pregnant or possible pregnant women 4)Patients who will undergo MRI 2 weeks after colon capsule endoscopy 5)Patients with small and large bowel obstruction 6)Patients with stricture in small and large bowel 7)Patients with glucose-6-phosphate dehydrogenase deficiency
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method